Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Clinical and Magnetic Resonance Imaging (MRI) Decision Making Rules in Differentiating Vaso-Occlusive Crises (VOCs) from Osteomyelitis in Paediatric Sickle Cell Population: Is MRI Pathognomonic?

Ahmed khalifa Al Shukaili, MD, Ahmed Abdullah Al Kharusi, MD, Eyad Tbaileh, MD, Hanan Nazir, Sameer Raniga, Alaa Al Manzalawy, Mohamed Ebrahim Mohamed Ebrahim Elshinawy, MD, Zaid Al Hinai, Laila Al Yazidi, Murtadha Al-Khabori, MD, Yasser Wali

Blood (2019) 134 (Supplement_1): 4824.

https://doi.org/10.1182/blood-2019-130861

Published: 2019

Journal Articles

Urinary Cross-Linked Carboxyterminal Telopeptide Decreases with Resolution of Painful Vaso-Occlusive Crises in Adults with Sickle Cell Disease - Results from the Sickle Cell Pain Markers (SCPM) Study

Oyebimpe O. Adesina, MD, Isaac C. Jenkins, MS, Qian V. Wu, PhD, Ellen B. Fung, PhD RD, CCD, Kanika Mahajan, Rebecca Kruse-Jarres, MDMPH

Blood (2018) 132 (Supplement 1): 1100.

https://doi.org/10.1182/blood-2018-99-119801

Published: 2018

Journal Articles

Relationship between Non-Prescribed Drug Use and Employment Status of Patients with Sickle Cell Disease

Modupe Idowu, MD, Tong Han Chung, PhD, Katherine Yu

Blood (2018) 132 (Supplement 1): 4932.

https://doi.org/10.1182/blood-2018-99-120373

Published: 2018

Journal Articles

The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Ferras Alashkar, MD, Haemi Schemuth, MD, Felix Nensa, MD, Ulrich Dührsen, MD, Thomas Wilfried Schlosser, MD, Alexander Röth, MD

Blood (2016) 128 (22): 1271.

https://doi.org/10.1182/blood.V128.22.1271.1271

Published: 2016

Journal Articles

Evaluating Causes of Back Pain in Patients with Sickle Cell Disease

Andrea R Whitfield, DO, Julie Kanter, MD

Blood (2015) 126 (23): 4593.

https://doi.org/10.1182/blood.V126.23.4593.4593

Published: 2015

Journal Articles

An Unsuspected Dyserythropoiesis in Gaucher Disease

Niloofar Reihani, PhD, Jean-Benoît Arlet, MD PhD, Thierry Billette de Villemeur, MD PhD, Nadia Belmatoug, MD, Yves Colin, PhD, Olivier Hermine, MD PhD, Caroline Le Van Kim, PhD, Mélanie Franco, PhD

Blood (2014) 124 (21): 1344.

https://doi.org/10.1182/blood.V124.21.1344.1344

Published: 2014

Journal Articles

Long Term Outcomes of ERT in Children with Gaucher Disease. Spanish Experience

Marcio M Andrade, MD, Pilar Alfonso, PhD, Pilar Irún, PhD, Javier Dalmau, MD, Jose Luis Barbera, MD, Horacio Cano, MD, María Angeles Fernandez-Galan, MD, Rafael Franco, MD, Inmaculada Garcia, MD, Angela IbaÃ±ez, MD, Francisco Lendinez, MD, Elena Martin-Hernandez, MD, Luis Antonio Sancho-Val, MD, Pablo Sanjurjo, MDPhD, Miguel Pocovi, Prof, Pilar Giraldo, MD PhD

Blood (2014) 124 (21): 4950.

https://doi.org/10.1182/blood.V124.21.4950.4950

Published: 2014

Journal Articles

Novel Management of Immune Thrombocytopenia in Gaucher Disease Patients

Hanna Rosenbaum, MD

Blood (2014) 124 (21): 5006.

https://doi.org/10.1182/blood.V124.21.5006.5006

Published: 2014

Journal Articles

Super-Elevated LDH and Thombocytopenia Are Markers Of An Unusual Sickle Phenomenon

Kate Gardner, MBBS MRCP, Emma Drasar, MBBS MRCP, Moji Awogbade, MD, Marlene Allman, Swee Lay Thein, MBBS, DSc

Blood (2013) 122 (21): 2220.

https://doi.org/10.1182/blood.V122.21.2220.2220

Published: 2013

Journal Articles

Low Bone Density In Sickle Cell Disease Is a Risk Factor in The Development Of Avascular Necrosis

Hassan A. Al-Jafar, MBChB , MD, Leena M Aytoglu, BSC - MSC ( Master in molecular medecine ), Jehan Al-Shemmari, PhD, Uzma Afzal, Iman Al-Shemmari, Saud Al-Enizi

Blood (2013) 122 (21): 4688.

https://doi.org/10.1182/blood.V122.21.4688.4688

Published: 2013

Journal Articles

Gaucher Disease and Multiple Myeloma: A Diagnostic and Treatment Challenge

Hanna Rosenbaum, MD, Irit Avivi, MD, Eliezer A. Rachmilewitz, Paulina Petchenko, MD

Blood (2011) 118 (21): 2166.

https://doi.org/10.1182/blood.V118.21.2166.2166

Published: 2011

Journal Articles

Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial,

M. Judith Peterschmitt, MD, Ravi S Kamath, MD, Elena Lukina, PhD, MD, Nora Watman, MD, Marta Dragosky, M.D., Marcelo Iastrebner, M.D., Gregory M Pastores, Elsa Avila Arreguin, M.D., Mici Phillips, M.D., Hanna Rosenbaum, MD, Elena Sysoeva, Rasha Aguzzi, Leorah H Ross, Ana Cristina Puga, M.D., Daniel I Rosenthal, M.D.

Blood (2011) 118 (21): 3216.

https://doi.org/10.1182/blood.V118.21.3216.3216

Published: 2011

Journal Articles

The Uptake of Recombinant Glucocerebrosidases by Blood Monocytes From Type 1 Gaucher Disease Patients Is Heterogeneous

Juliette Berger, Jérome Stirnemann, MD, PhD, Céline Bourgne, Bruno Pereira, Pascale Pigeon, Djazia Heraoui, Chantal Rapatel, Christian Rose, MD, PhD, Nadia Belmatoug, MD, Marc G Berger, MD, PhD

Blood (2011) 118 (21): 1102.

https://doi.org/10.1182/blood.V118.21.1102.1102

Published: 2011

Journal Articles

Eliglustat Tartrate, a Novel Investigational Oral Substrate Reduction Therapy for Gaucher Disease Type 1: Updated Phase 2 Results.

Elena Lukina, Judith Peterschmitt, Nora Watman, Marta Dragosky, Marcelo Iastrebner, Gregory Pastores, Elsa Avila Arreguin, Hanna Rosenbaum, Mici Phillips, Mathilde Kaper, Arshadul Haque, Ana Cristina Puga

Blood (2010) 116 (21): 3791.

https://doi.org/10.1182/blood.V116.21.3791.3791

Published: 2010

Journal Articles

Measurement of Urine Pyridinoline and Deoxypyridinoline as Markers of Increased Bone Degradation in Sickle Cell Disease.

Erfan Nur, MD, Willem Mairuhu, Dees P. Brandjes, MD, PhD, Ton van Zanten, Bart J. Biemond, MD, PhD, Hans-Martin Otten, MD, PhD

Blood (2009) 114 (22): 2572.

https://doi.org/10.1182/blood.V114.22.2572.2572

Published: 2009

Journal Articles

Hydroxyurea in the Management of Pediatric Sickle Cell Patients

Amal M. El-Beshlawy, MA

Blood (2008) 112 (11): 4818.

https://doi.org/10.1182/blood.V112.11.4818.4818

Published: 2008

Journal Articles

S-MRI Score as a Simple Method To Assess Bone Marrow Involvement in Gaucher Disease.

Mercedes Roca, MD, PhD, Juan Mota, MD PhD, Pilar Alfonso, PhD, Manuel Giralt, MD PhD, Miguel Pocovi, PhD, Pilar Giraldo, MD, PhD

Blood (2006) 108 (11): 3836.

https://doi.org/10.1182/blood.V108.11.3836.3836

Published: 2006

Journal Articles

Evaluation of Bone Mineral Density in Children with Sickle Cell Anemia.

Ashutosh Lal, MD, Ellen Fung, PhD, Bamidele Kammen, MD, Zahra Pakbaz, MD, Nancy Sweeters, PNP, Ekua Hackney-Stevens, PNP, Keith Quirolo, MD, Elliott Vichinsky, MD

Blood (2004) 104 (11): 106.

https://doi.org/10.1182/blood.V104.11.106.106

Published: 2004

Journal Articles

Enzymatic Replacement Therapy (ERT) with Low Doses in Gaucher Disease in the State of Sao Paulo (Brazil).

Elisa A.P. Sobreira, MD, Tereza C. Bortolheiro, MD, Ana M. Martins, MD, PhD, Gilda Porta, MD, PhD

Blood (2004) 104 (11): 5312.

https://doi.org/10.1182/blood.V104.11.5312.5312

Published: 2004

Journal Articles

Adults with Severe Sickle Cell Anaemia and Iron Overload Have a High Incidence of Osteopenia and Osteoporosis.

Farrukh T. Shah, Ratna Chatterjee, Matilda Owusu-Asante, John B. Porter

Blood (2004) 104 (11): 1684.

https://doi.org/10.1182/blood.V104.11.1684.1684

Published: 2004

NARROW

Clinical and Magnetic Resonance Imaging (MRI) Decision Making Rules in Differentiating Vaso-Occlusive Crises (VOCs) from Osteomyelitis in Paediatric Sickle Cell Population: Is MRI Pathognomonic?

Urinary Cross-Linked Carboxyterminal Telopeptide Decreases with Resolution of Painful Vaso-Occlusive Crises in Adults with Sickle Cell Disease - Results from the Sickle Cell Pain Markers (SCPM) Study

Relationship between Non-Prescribed Drug Use and Employment Status of Patients with Sickle Cell Disease

The Role of Whole-Body Magnetic Resonance Imaging (WB-MRI) in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Evaluating Causes of Back Pain in Patients with Sickle Cell Disease

An Unsuspected Dyserythropoiesis in Gaucher Disease

Long Term Outcomes of ERT in Children with Gaucher Disease. Spanish Experience

Novel Management of Immune Thrombocytopenia in Gaucher Disease Patients

Super-Elevated LDH and Thombocytopenia Are Markers Of An Unusual Sickle Phenomenon

Low Bone Density In Sickle Cell Disease Is a Risk Factor in The Development Of Avascular Necrosis

Gaucher Disease and Multiple Myeloma: A Diagnostic and Treatment Challenge

Improvements in Skeletal Manifestations in Gaucher Disease Type 1 Patients After 3 Years of Treatment with Oral Eliglustat During a Phase 2 Trial,

The Uptake of Recombinant Glucocerebrosidases by Blood Monocytes From Type 1 Gaucher Disease Patients Is Heterogeneous

Eliglustat Tartrate, a Novel Investigational Oral Substrate Reduction Therapy for Gaucher Disease Type 1: Updated Phase 2 Results.

Measurement of Urine Pyridinoline and Deoxypyridinoline as Markers of Increased Bone Degradation in Sickle Cell Disease.

Hydroxyurea in the Management of Pediatric Sickle Cell Patients

S-MRI Score as a Simple Method To Assess Bone Marrow Involvement in Gaucher Disease.

Evaluation of Bone Mineral Density in Children with Sickle Cell Anemia.

Enzymatic Replacement Therapy (ERT) with Low Doses in Gaucher Disease in the State of Sao Paulo (Brazil).

Adults with Severe Sickle Cell Anaemia and Iron Overload Have a High Incidence of Osteopenia and Osteoporosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only